Assembly Biosciences, Inc. Comprehensive Income
Assembly Biosciences, Inc. (ASMB) reported Comprehensive Income of -$4.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-13
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$4.11M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$9.41M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $22.14M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$9.01M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$5.95M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$40.31M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$60.51M.
- Assembly Biosciences, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$93.48M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.11M 10-Q · filed 2026-08-13 | -$13.52M 10-Q · filed 2026-08-13 | $8.62M derived: sum of 3 quarters · filed 2026-08-13 | -$386.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$9.41M 10-Q · filed 2026-05-07 | $12.73M derived: sum of 2 quarters · filed 2026-05-07 | $3.73M derived: sum of 3 quarters · filed 2026-05-07 | -$6.50M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $22.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $13.13M derived: sum of 2 quarters · filed 2026-03-19 | $2.91M derived: sum of 3 quarters · filed 2026-08-13 | -$5.95M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | -$9.01M 10-Q · filed 2025-11-10 | -$19.23M derived: sum of 2 quarters · filed 2026-08-13 | -$28.09M 10-Q · filed 2025-11-10 | -$38.48M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$10.22M 10-Q · filed 2026-08-13 | -$19.08M 10-Q · filed 2026-08-13 | -$29.47M derived: sum of 3 quarters · filed 2026-08-13 | -$38.95M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$8.86M 10-Q · filed 2026-05-07 | -$19.25M derived: sum of 2 quarters · filed 2026-05-07 | -$28.73M derived: sum of 3 quarters · filed 2026-05-07 | -$39.93M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$10.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$19.87M derived: sum of 2 quarters · filed 2026-03-19 | -$31.07M derived: sum of 3 quarters · filed 2026-03-19 | -$40.31M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | -$9.48M 10-Q · filed 2025-11-10 | -$20.68M derived: sum of 2 quarters · filed 2025-11-10 | -$29.92M 10-Q · filed 2025-11-10 | -$40.69M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$11.21M 10-Q · filed 2025-08-06 | -$20.44M 10-Q · filed 2025-08-06 | -$31.21M derived: sum of 3 quarters · filed 2025-08-06 | -$45.58M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$9.23M 10-Q · filed 2025-05-08 | -$20.00M derived: sum of 2 quarters · filed 2025-05-08 | -$34.37M derived: sum of 3 quarters · filed 2025-05-08 | -$51.08M derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$25.14M derived: sum of 2 quarters · filed 2025-03-20 | -$41.85M derived: sum of 3 quarters · filed 2025-03-20 | -$60.51M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$14.37M 10-Q · filed 2024-11-07 | -$31.08M derived: sum of 2 quarters · filed 2024-11-07 | -$49.74M 10-Q · filed 2024-11-07 | -$71.94M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$16.71M 10-Q · filed 2024-08-08 | -$35.37M 10-Q · filed 2024-08-08 | -$57.57M derived: sum of 3 quarters · filed 2024-08-08 | -$80.71M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$18.66M 10-Q · filed 2024-05-08 | -$40.86M derived: sum of 2 quarters · filed 2024-05-08 | -$64.00M derived: sum of 3 quarters · filed 2024-05-08 | -$88.56M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$22.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$45.34M derived: sum of 2 quarters · filed 2024-03-28 | -$69.90M derived: sum of 3 quarters · filed 2024-03-28 | -$93.48M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | -$23.15M 10-Q · filed 2023-11-08 | -$47.70M derived: sum of 2 quarters · filed 2023-11-08 | -$71.28M 10-Q · filed 2023-11-08 | -$131.66M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | -$24.55M 10-Q · filed 2023-08-09 | -$48.13M 10-Q · filed 2023-08-09 | -$108.52M derived: sum of 3 quarters · filed 2023-08-09 | -$127.34M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$23.58M 10-Q · filed 2023-05-04 | -$83.97M derived: sum of 2 quarters · filed 2023-05-04 | -$102.79M derived: sum of 3 quarters · filed 2023-05-04 | -$126.38M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$60.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$79.21M derived: sum of 2 quarters · filed 2023-03-22 | -$102.80M derived: sum of 3 quarters · filed 2023-03-22 | -$130.00M 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | -$18.82M 10-Q · filed 2022-11-08 | -$42.41M derived: sum of 2 quarters · filed 2022-11-08 | -$69.62M 10-Q · filed 2022-11-08 | -$109.15M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$23.60M 10-Q · filed 2022-08-09 | -$50.80M 10-Q · filed 2022-08-09 | -$90.33M derived: sum of 3 quarters · filed 2022-08-09 | -$93.94M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$27.20M 10-Q · filed 2022-05-12 | -$66.73M derived: sum of 2 quarters · filed 2022-05-12 | -$70.34M derived: sum of 3 quarters · filed 2022-05-12 | -$62.88M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$39.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$43.14M derived: sum of 2 quarters · filed 2022-03-11 | -$35.68M derived: sum of 3 quarters · filed 2022-03-11 | -$62.22M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | -$3.61M 10-Q · filed 2021-11-04 | $3.85M derived: sum of 2 quarters · filed 2021-11-04 | -$22.69M 10-Q · filed 2021-11-04 | -$49.77M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $7.46M 10-Q · filed 2021-08-05 | -$19.08M 10-Q · filed 2021-08-05 | -$46.16M derived: sum of 3 quarters · filed 2021-08-05 | -$71.17M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$26.54M 10-Q · filed 2021-05-06 | -$53.62M derived: sum of 2 quarters · filed 2021-05-06 | -$78.63M derived: sum of 3 quarters · filed 2021-05-06 | -$97.08M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$27.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$52.09M derived: sum of 2 quarters · filed 2021-02-25 | -$70.54M derived: sum of 3 quarters · filed 2021-02-25 | -$97.49M 10-K · filed 2021-02-25 | ||||
| 2019-09-30 | -$25.01M 10-Q · filed 2020-11-05 | -$43.46M derived: sum of 2 quarters · filed 2020-11-05 | -$70.41M 10-Q · filed 2020-11-05 | -$96.56M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$18.45M 10-Q · filed 2020-08-05 | -$45.40M 10-Q · filed 2020-08-05 | -$71.55M derived: sum of 3 quarters · filed 2021-02-25 | -$93.07M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$26.94M 10-Q · filed 2020-05-08 | -$53.10M derived: sum of 2 quarters · filed 2021-02-25 | -$74.61M derived: sum of 3 quarters · filed 2021-02-25 | -$101.33M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$26.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$47.67M derived: sum of 2 quarters · filed 2021-02-25 | -$74.39M derived: sum of 3 quarters · filed 2021-02-25 | -$90.71M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$21.52M 10-Q · filed 2019-11-07 | -$21.52M 10-Q · filed 2018-11-08 | -$48.24M derived: sum of 2 quarters · filed 2019-11-07 | -$64.55M 10-Q · filed 2019-11-07 | -$64.55M 10-Q · filed 2018-11-08 | -$67.56M derived: sum of 4 quarters · filed 2020-03-04 | ||
| 2018-06-30 | -$26.72M 10-Q · filed 2019-08-05 | -$26.72M 10-Q · filed 2018-08-08 | -$43.03M 10-Q · filed 2019-08-05 | -$43.03M 10-Q · filed 2018-08-08 | -$46.05M derived: sum of 3 quarters · filed 2020-03-04 | -$58.31M derived: sum of 4 quarters · filed 2020-03-04 | ||
| 2018-03-31 | -$16.32M 10-Q · filed 2019-05-09 | -$16.32M 10-Q · filed 2018-05-07 | -$19.33M derived: sum of 2 quarters · filed 2020-03-04 | -$31.59M derived: sum of 3 quarters · filed 2020-03-04 | -$45.06M derived: sum of 4 quarters · filed 2020-03-04 | |||
| 2017-12-31 | -$3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$15.27M derived: sum of 2 quarters · filed 2020-03-04 | -$28.75M derived: sum of 3 quarters · filed 2020-03-04 | -$42.60M 10-K · filed 2020-03-04 | -$42.60M 10-K · filed 2018-03-08 | |||
| 2017-09-30 | -$12.26M 10-Q · filed 2018-11-08 | -$25.73M derived: sum of 2 quarters · filed 2018-11-08 | -$39.59M 10-Q · filed 2018-11-08 | -$50.90M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | -$13.47M 10-Q · filed 2018-08-08 | -$27.33M 10-Q · filed 2018-08-08 | -$38.64M derived: sum of 3 quarters · filed 2019-02-28 | -$50.21M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | -$13.85M 10-Q · filed 2018-05-07 | -$25.16M derived: sum of 2 quarters · filed 2019-02-28 | -$36.74M derived: sum of 3 quarters · filed 2019-02-28 | -$46.98M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | -$11.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$22.88M derived: sum of 2 quarters · filed 2019-02-28 | -$33.12M derived: sum of 3 quarters · filed 2019-02-28 | -$44.04M 10-K · filed 2019-02-28 | -$44.04M 10-K · filed 2017-03-02 | |||
| 2016-09-30 | -$11.57M 10-Q · filed 2017-11-01 | -$21.81M derived: sum of 2 quarters · filed 2017-11-01 | -$32.73M 10-Q · filed 2017-11-01 | -$40.91M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | -$10.24M 10-Q · filed 2017-08-09 | -$21.16M 10-Q · filed 2017-08-09 | -$29.34M derived: sum of 3 quarters · filed 2018-03-08 | -$36.21M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | -$10.92M 10-Q · filed 2017-05-08 | -$19.10M derived: sum of 2 quarters · filed 2018-03-08 | -$25.97M derived: sum of 3 quarters · filed 2018-03-08 | -$33.05M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2015-12-31 | -$8.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$15.05M derived: sum of 2 quarters · filed 2018-03-08 | -$22.13M derived: sum of 3 quarters · filed 2018-03-08 | -$29.28M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | -$6.87M 10-Q · filed 2016-11-09 | -$13.95M derived: sum of 2 quarters · filed 2016-11-09 | -$21.09M 10-Q · filed 2016-11-09 | -$27.32M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | -$7.08M 10-Q · filed 2016-08-09 | -$14.22M 10-Q · filed 2016-08-09 | -$20.45M derived: sum of 3 quarters · filed 2017-03-02 | -$31.47M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-03-31 | -$7.14M 10-Q · filed 2016-05-10 | -$13.37M derived: sum of 2 quarters · filed 2017-03-02 | -$24.39M derived: sum of 3 quarters · filed 2017-03-02 | -$26.86M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2014-12-31 | -$6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | -$17.25M derived: sum of 2 quarters · filed 2017-03-02 | -$19.72M derived: sum of 3 quarters · filed 2017-03-02 | -$23.79M 10-K · filed 2017-03-02 | ||||
| 2014-09-30 | -$11.02M 10-Q · filed 2015-11-09 | -$13.49M derived: sum of 2 quarters · filed 2015-11-09 | -$17.56M 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | -$2.47M 10-Q · filed 2015-08-13 | -$6.54M 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |